{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:55:13Z","timestamp":1776869713556,"version":"3.51.2"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Gastric SMARCA4-deficient carcinosarcoma and sarcomatoid carcinoma are rare with poor prognosis. In the present study, two male patients were hospitalized due to abdominal manifestations, specifically abdominal pain and a sense of fullness and discomfort. Gastroscopic examination revealed huge raised lesions in the stomach of both individuals, subsequently leading to laparoscopic radical total gastrectomy. Histopathological analysis of surgical specimens obtained from both patients demonstrated the presence of carcinomatous and sarcomatous components. In Case 1, the sarcoma region was negative for the SMARCA4, epithelial markers cytokeratin (CK) and epithelial membrane antigen (EMA), CK, EMA, and SMARCA4 were positively expressed in the adenocarcinoma area, thereby warranting carcinosarcoma diagnosis. The sarcomatous component was identified as a tumor characterized by SMARCA4 deficiency. In Case 2, the tumor cells exhibited positive staining for CK and Vimentin, negative staining for SMARCA4, and the patient was positive for SMARCA4-deficient sarcomatoid carcinoma.<\/jats:p>","DOI":"10.3389\/fonc.2025.1663811","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:23:20Z","timestamp":1760502200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Primary gastric SMARCA4-deficient carcinosarcoma and sarcomatoid carcinoma: Two case reports"],"prefix":"10.3389","volume":"15","author":[{"given":"Ran","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1038\/s41467-020-19402-8","article-title":"Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients","volume":"11","author":"Fernando","year":"2020","journal-title":"Nat Commun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6083","article-title":"Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer","volume":"12","author":"Liang","year":"2023","journal-title":"Cancer Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nature11284","article-title":"Dissecting the genomic complexity underlying medulloblastoma","volume":"488","author":"Jones","year":"2012","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nature11329","article-title":"Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations","volume":"488","author":"Pugh","year":"2012","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-4598-8-4","article-title":"The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a","volume":"8","author":"Becker","year":"2009","journal-title":"Mol Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/his.14117","article-title":"The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression","volume":"77","author":"Huang","year":"2020","journal-title":"Histopathology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012917","article-title":"The SWI\/SNF complex mutations in gynecologic cancers: molecular mechanisms and models","volume":"15","author":"Wang","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/00031348221146972","article-title":"Identification and treatment of SMARCA4 deficient poorly differentiated gastric carcinoma","author":"Bhat","year":"2022","journal-title":"Am Surgeon"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-022-01602-y","article-title":"SMARCA4-deficient rectal carcinoma with a sarcomatoid component: a case report","volume":"15","author":"Meda","year":"2022","journal-title":"Clin J Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAS.0000000000002172","article-title":"Colorectal carcinoma with sarcomatoid components report of 15 cases and literature review of an exceedingly rare carcinoma subtype","author":"Golconda","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e24697","DOI":"10.1097\/MD.0000000000024697","article-title":"Carcinosarcoma and sarcomatoid carcinoma of the stomach: Two case reports","volume":"100","author":"Li","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1038\/s41467-021-25260-9","article-title":"SMARCA4\/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria","volume":"12","author":"Xue","year":"2021","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"154692","DOI":"10.1016\/j.prp.2023.154692","article-title":"Esophageal carcinoma with SMARCA4 mutation: Unique diagnostic challenges","volume":"248","author":"Cui","year":"2023","journal-title":"Pathol - Res Pract"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-022-01606-8","article-title":"The first case of SMARCA4\u2212deficient sarcoma of stomach","volume":"15","author":"Ota","year":"2022","journal-title":"Clin J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1038\/s41467-022-34562-5","article-title":"Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers","volume":"13","author":"Cantley","year":"2022","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","article-title":"SMARCA4 and SMARCA2 deficiency in non\u2013small cell lung cancer: immunohistochemical survey of 316 consecutive specimens","volume":"26","author":"Herpel","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1265\/ehpm.21-00254","article-title":"SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution","volume":"27","author":"Sun","year":"2022","journal-title":"Environ Health Prev Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12885-019-6425-3","article-title":"Loss of the SWI\/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma","volume":"20","author":"Schallenberg","year":"2020","journal-title":"BMC Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-023-02403-0","article-title":"Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model","volume":"28","author":"Zhang","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245356","article-title":"The clinicopathological significance of SWI\/SNF alterations in gastric cancer is associated with the molecular subtypes","volume":"16","author":"Suzuki","year":"2021","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/his.14612","article-title":"Switch\/sucrose-non-fermentable (SWI\/SNF) complex (SMARCA4, SMARCA2, INI1\/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas","volume":"80","author":"Ahadi","year":"2022","journal-title":"Histopathology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/his.12334","article-title":"Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma","volume":"64","author":"Xia","year":"2014","journal-title":"Histopathology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2643","article-title":"The mutational landscape of adenoid cystic carcinoma","volume":"45","author":"Ho","year":"2013","journal-title":"Nat Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.129","article-title":"Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type","volume":"29","author":"Jelinic","year":"2016","journal-title":"Modern Pathol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/path.4633","article-title":"Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type","volume":"238","author":"Karnezis","year":"2015","journal-title":"J Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.61","article-title":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","volume":"30","author":"Sauter","year":"2017","journal-title":"Modern Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/his.13091","article-title":"Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology","volume":"70","author":"Ramalingam","year":"2017","journal-title":"Histopathology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1038\/s41467-021-24618-3","article-title":"SMARCA4 deficient tumours are vulnerable to KDM6A\/UTX and KDM6B\/JMJD3 blockade","volume":"12","author":"Romero","year":"2021","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"107471","DOI":"10.1016\/j.lungcan.2024.107471","article-title":"Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy","volume":"189","author":"Zhou","year":"2024","journal-title":"Lung Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1663811\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:23:22Z","timestamp":1760502202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1663811\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":33,"alternative-id":["10.3389\/fonc.2025.1663811"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1663811","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1663811"}}